| Application number | Title of the application | Filing Date | Status |
|---|
| 09/674853 | Genetically-modified fibroblasts and the use thereof | Nov 6, 2000 | Abandoned |
Array
(
[id] => 4639563
[patent_doc_number] => 08017590
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-09-13
[patent_title] => 'Method of inducing and/or enhancing an immune response to tumor antigens'
[patent_app_type] => utility
[patent_app_number] => 09/693754
[patent_app_country] => US
[patent_app_date] => 2000-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 11274
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017590.pdf
[firstpage_image] =>[orig_patent_app_number] => 09693754
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693754 | Method of inducing and/or enhancing an immune response to tumor antigens | Oct 19, 2000 | Issued |
Array
(
[id] => 758063
[patent_doc_number] => 07015205
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-21
[patent_title] => 'Melanoma vaccine and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 09/691504
[patent_app_country] => US
[patent_app_date] => 2000-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12676
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015205.pdf
[firstpage_image] =>[orig_patent_app_number] => 09691504
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/691504 | Melanoma vaccine and methods of making and using same | Oct 17, 2000 | Issued |
| 09/673292 | Transporter protein splice variants and model for immune diversity | Oct 12, 2000 | Abandoned |
Array
(
[id] => 1056582
[patent_doc_number] => 06855806
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-15
[patent_title] => 'Thymosin beta 10-like proteins and nucleic acids encoding same'
[patent_app_type] => utility
[patent_app_number] => 09/689486
[patent_app_country] => US
[patent_app_date] => 2000-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 36236
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/855/06855806.pdf
[firstpage_image] =>[orig_patent_app_number] => 09689486
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/689486 | Thymosin beta 10-like proteins and nucleic acids encoding same | Oct 11, 2000 | Issued |
Array
(
[id] => 701705
[patent_doc_number] => 07064111
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-20
[patent_title] => 'Use of soluble costimulatory factor for tumor immuno-gene therapy'
[patent_app_type] => utility
[patent_app_number] => 09/679147
[patent_app_country] => US
[patent_app_date] => 2000-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2967
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/064/07064111.pdf
[firstpage_image] =>[orig_patent_app_number] => 09679147
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/679147 | Use of soluble costimulatory factor for tumor immuno-gene therapy | Oct 4, 2000 | Issued |
| 09/672665 | Novel polynucleotides and polypeptides encoded thereby | Sep 27, 2000 | Abandoned |
| 09/530504 | Hematopoietic stem cells | Sep 24, 2000 | Abandoned |
Array
(
[id] => 418565
[patent_doc_number] => 07276234
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-10-02
[patent_title] => 'Method of acquiring immunological tolerance'
[patent_app_type] => utility
[patent_app_number] => 09/889321
[patent_app_country] => US
[patent_app_date] => 2000-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4805
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276234.pdf
[firstpage_image] =>[orig_patent_app_number] => 09889321
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/889321 | Method of acquiring immunological tolerance | Sep 18, 2000 | Issued |
Array
(
[id] => 975342
[patent_doc_number] => 06933145
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-23
[patent_title] => 'Materials and methods for delivery and expression of heterologous DNA in vertebrate cells'
[patent_app_type] => utility
[patent_app_number] => 09/662254
[patent_app_country] => US
[patent_app_date] => 2000-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 27
[patent_no_of_words] => 32008
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/933/06933145.pdf
[firstpage_image] =>[orig_patent_app_number] => 09662254
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/662254 | Materials and methods for delivery and expression of heterologous DNA in vertebrate cells | Sep 13, 2000 | Issued |
| 09/653722 | GENERATION OF XENOGENEIC ANTIBODIES | Aug 31, 2000 | Abandoned |
Array
(
[id] => 488226
[patent_doc_number] => 07214371
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-08
[patent_title] => 'Tissue engineered biografts for repair of damaged myocardium'
[patent_app_type] => utility
[patent_app_number] => 09/654276
[patent_app_country] => US
[patent_app_date] => 2000-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5639
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214371.pdf
[firstpage_image] =>[orig_patent_app_number] => 09654276
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/654276 | Tissue engineered biografts for repair of damaged myocardium | Aug 31, 2000 | Issued |
| 09/650359 | Compositions and methods for therapeutic use | Aug 27, 2000 | Abandoned |
Array
(
[id] => 1398479
[patent_doc_number] => 06531456
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => 'Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors'
[patent_app_type] => B1
[patent_app_number] => 09/649890
[patent_app_country] => US
[patent_app_date] => 2000-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 19905
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531456.pdf
[firstpage_image] =>[orig_patent_app_number] => 09649890
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/649890 | Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors | Aug 27, 2000 | Issued |
Array
(
[id] => 7645386
[patent_doc_number] => 06472585
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Cardiotrophin-1 defective mouse'
[patent_app_type] => B1
[patent_app_number] => 09/648183
[patent_app_country] => US
[patent_app_date] => 2000-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32577
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09648183
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/648183 | Cardiotrophin-1 defective mouse | Aug 24, 2000 | Issued |
Array
(
[id] => 662527
[patent_doc_number] => 07101704
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-05
[patent_title] => 'Antigen presenting mesenchymal stem cells'
[patent_app_type] => utility
[patent_app_number] => 09/638358
[patent_app_country] => US
[patent_app_date] => 2000-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8555
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101704.pdf
[firstpage_image] =>[orig_patent_app_number] => 09638358
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/638358 | Antigen presenting mesenchymal stem cells | Aug 14, 2000 | Issued |
| 09/637848 | Compositions and methods for mediating cell cycle progression | Aug 9, 2000 | Abandoned |
Array
(
[id] => 1210273
[patent_doc_number] => 06713610
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Human antibodies derived from immunized xenomice'
[patent_app_type] => B1
[patent_app_number] => 09/614092
[patent_app_country] => US
[patent_app_date] => 2000-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 26
[patent_no_of_words] => 13688
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713610.pdf
[firstpage_image] =>[orig_patent_app_number] => 09614092
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/614092 | Human antibodies derived from immunized xenomice | Jul 10, 2000 | Issued |
Array
(
[id] => 1466838
[patent_doc_number] => 06458592
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Production of antibodies using cre-mediated site-specific recombination'
[patent_app_type] => B1
[patent_app_number] => 09/610259
[patent_app_country] => US
[patent_app_date] => 2000-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12466
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458592.pdf
[firstpage_image] =>[orig_patent_app_number] => 09610259
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/610259 | Production of antibodies using cre-mediated site-specific recombination | Jul 4, 2000 | Issued |
Array
(
[id] => 1224561
[patent_doc_number] => 06699972
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => 'Chimeric protein and method of controlling tumor growth using the protein'
[patent_app_type] => B1
[patent_app_number] => 09/602263
[patent_app_country] => US
[patent_app_date] => 2000-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 28
[patent_no_of_words] => 9997
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699972.pdf
[firstpage_image] =>[orig_patent_app_number] => 09602263
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/602263 | Chimeric protein and method of controlling tumor growth using the protein | Jun 22, 2000 | Issued |